CliffBio
small molecule

FLONASE ALLERGY RELIEF

FLUTICASONE PROPIONATE

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameFLONASE ALLERGY RELIEF
Active ingredientFLUTICASONE PROPIONATE
Strength0.05MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalJuly 2014
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.